Search

everythinglearnresearchcommunity

for

Search:↓

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

p21waf1/cip1 and p27kip1 help in hair follicle differentiation in rats.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Kangfuxin (KFX) extract speeds up wound healing and improves skin regeneration.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.

Some natural compounds from Iris plants can block enzymes related to certain disorders, with a few affecting both targeted enzymes.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

The drug combination was safe and showed promise in treating advanced tumors.

Compounds from Etlingera alba may help treat Triple Negative Breast Cancer.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Minoxidil sulfate and pinacidil may promote hair growth through increased blood flow, not by activating potassium channels.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

The ingredients could help prevent hair loss by promoting hair growth and increasing VEGF secretion.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

The extracts may help hair growth.

Janus kinase inhibitors show promise for treating alopecia areata but need more research for confirmation.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Tofacitinib and oral minoxidil may help treat Sisaipho alopecia areata.

Sgk3 is essential for normal hair follicle growth and maintenance.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

Astraglus polysaccharide may help hair growth by boosting follicle stem cell activity.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.